Sarepta Therapeutics to Announce Second Quarter 2023 Financial Results

Rhea-AI Summary

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) will report second quarter 2023 financial results on August 2, 2023, followed by a conference call. The event will be webcast live and a replay will be available for one year. Interested parties can register for dial-in details online.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report second quarter 2023 financial results after the Nasdaq Global Market closes on Wednesday, August 2, 2023. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its second quarter 2023 financial results.

The event will be webcast live under the investor relations section of Sarepta's website at https://investorrelations.sarepta.com/events-presentations and following the event a replay will be archived there for one year. Interested parties participating by phone will need to register using this online form. After registering for dial-in details, all phone participants will receive an auto-generated e-mail containing a link to the dial-in number along with a personal PIN number to use to access the event by phone.

About Sarepta Therapeutics

Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information

We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230726643986/en/

Investor Contact:

Ian Estepan, 617-274-4052

iestepan@sarepta.com



Media Contact:

Tracy Sorrentino, 617-301-8566

tsorrentino@sarepta.com

Source: Sarepta Therapeutics, Inc.

FAQ

What is the ticker symbol of Sarepta Therapeutics, Inc.?

The ticker symbol is SRPT.

When will Sarepta Therapeutics, Inc. report its second quarter 2023 financial results?

The company will report its results after the Nasdaq Global Market closes on Wednesday, August 2, 2023.

How can interested parties access the conference call?

Interested parties can access the conference call through the webcast link provided in the investor relations section of Sarepta's website.

Where can the replay of the conference call be found?

The replay will be archived on Sarepta's website for one year after the event.